Study finds β-synuclein as early blood-based biomarker of Alzheimer's in Down syndrome patients

News-Medical · October 7, 2026

Study finds β-synuclein as early blood-based biomarker of Alzheimer's in Down syndrome patients

Source:News-Medical

Comments

No comments yet.

Sign in to join the conversation.

Read original article